Developmental genome-wide DNA methylation asymmetry between mouse placenta and embryo

dc.contributor.authorLegault, L. M.
dc.contributor.authorDoiron, K.
dc.contributor.authorLemieux, A.
dc.contributor.authorCaron, M.
dc.contributor.authorChan, D.
dc.contributor.authorLopes, F. L. [UNESP]
dc.contributor.authorBourque, G.
dc.contributor.authorSinnett, D.
dc.contributor.authorMcGraw, S.
dc.contributor.institutionResearch Center of the CHU Sainte-Justine
dc.contributor.institutionUniversité De Montréal
dc.contributor.institutionResearch Institute of the McGill University Health Centre
dc.contributor.institutionUniversidade Estadual Paulista (Unesp)
dc.contributor.institutionMcGill University
dc.contributor.institutionMcGill University and Genome Quebec Innovation Centre
dc.contributor.institutionCanadian Center for Computational Genomics
dc.date.accessioned2020-12-12T01:15:07Z
dc.date.available2020-12-12T01:15:07Z
dc.date.issued2020-08-02
dc.description.abstractIn early embryos, DNA methylation is remodelled to initiate the developmental program but for mostly unknown reasons, methylation marks are acquired unequally between embryonic and placental cells. To better understand this, we generated high-resolution DNA methylation maps of mouse mid-gestation (E10.5) embryo and placenta. We uncovered specific subtypes of differentially methylated regions (DMRs) that contribute directly to the developmental asymmetry existing between mid-gestation embryonic and placental DNA methylation patterns. We show that the asymmetry occurs rapidly during the acquisition of marks in the post-implanted conceptus (E3.5-E6.5), and that these patterns are long-lasting across subtypes of DMRs throughout prenatal development and in somatic tissues. We reveal that at the peri–implantation stages, the de novo methyltransferase activity of DNMT3B is the main driver of methylation marks on asymmetric DMRs, and that DNMT3B can largely compensate for lack of DNMT3A in the epiblast and extraembryonic ectoderm, whereas DNMT3A can only partially compensate in the absence of DNMT3B. However, as development progresses and as DNMT3A becomes the principal de novo methyltransferase, the compensatory DNA methylation mechanism of DNMT3B on DMRs becomes less effective.en
dc.description.affiliationResearch Center of the CHU Sainte-Justine
dc.description.affiliationDepartment of Biochemistry and Molecular Medicine Université De Montréal
dc.description.affiliationResearch Institute of the McGill University Health Centre
dc.description.affiliationSchool of Veterinary Medicine São Paulo State University (Unesp)
dc.description.affiliationDepartment of Human Genetics McGill University
dc.description.affiliationMcGill University and Genome Quebec Innovation Centre
dc.description.affiliationCanadian Center for Computational Genomics
dc.description.affiliationDepartment of Pediatrics Université De Montréal
dc.description.affiliationDepartment of Obstetrics and Gynecology Université De Montréal
dc.description.affiliationUnespSchool of Veterinary Medicine São Paulo State University (Unesp)
dc.format.extent800-815
dc.identifierhttp://dx.doi.org/10.1080/15592294.2020.1722922
dc.identifier.citationEpigenetics, v. 15, n. 8, p. 800-815, 2020.
dc.identifier.doi10.1080/15592294.2020.1722922
dc.identifier.issn1559-2308
dc.identifier.issn1559-2294
dc.identifier.scopus2-s2.0-85079425521
dc.identifier.urihttp://hdl.handle.net/11449/198519
dc.language.isoeng
dc.relation.ispartofEpigenetics
dc.sourceScopus
dc.subjectDNA methylation
dc.subjectearly development
dc.subjectembryo
dc.subjectplacenta
dc.titleDevelopmental genome-wide DNA methylation asymmetry between mouse placenta and embryoen
dc.typeArtigo
unesp.author.orcid0000-0002-3733-5723[4]
unesp.author.orcid0000-0002-3173-3712[6]
unesp.author.orcid0000-0002-3933-9656[7]
unesp.author.orcid0000-0002-3504-8253[9]

Arquivos

Coleções